Our promise to you:
Guaranteed product quality, expert customer support.
Cells use intricate gene networks to adapt to a variety of situations and surroundings. High-throughput genome-wide screening is made possible by CRISPR technology, which makes it easier to identify gene targets associated with certain phenotypes or to customize cellular function. Prior to the development of CRISPR technology, RNA interference (RNAi)-based screening was extensively used; however, because of poor gene suppression and off-target effects on mRNA, it was difficult to correlate phenotypes with gene knockdown.
Using a gRNA library for CRISPR-Cas screening has shown to be an effective method for identifying the genes, pathways, and processes linked to certain biological features or phenotypes. The identification of genes associated with bacterial invasion and resistance to chemicals or antibiotics has been made possible through the use of CRISPR-Cas9 screening. However, because CRISPR knockdown (CRISPR-KO) screening results in irreversible gene disruption, it is not able to reversibly modulate gene expression.
CRISPRi/a was created to overcome this restriction by allowing for the reversible expression of genes and the tweaking of their levels for screening purposes. A useful synthetic biology method that clarifies the connection between genotype and phenotype and identifies engineering targets in intricate cellular networks is genome-wide CRISPRi/a screening. There are two common ways to perform CRISPRi screening: arrayed and pooled methods.
Figure 1. Pooled and Arrayed CRISPR Screening (A) Pooled screening: cells are treated to a combination of Cas9 vector and sgRNA library delivery. High-throughput facilities use sgRNA sequencing to identify target genes and screen cells with certain characteristics. (B) Arrayed Screening: Individual cells are treated to independent delivery of the Cas9 and sgRNA vectors. The production of the chosen cells with the required characteristics is examined. (Jeong SH, et al., 2023)
Target genes in pooled CRISPR screening are found by sequencing the sgRNA isolated from cells exhibiting certain phenotypic changes following the introduction of a large sgRNA library. For example, an E. coli sgRNA library containing around 60,000 sgRNAs was used to screen for genes relevant to auxotrophic response and antibiotic resistance.
One sgRNA targeting one gene per well is inserted into cells in a multi-well plate during arrayed CRISPRi screening, and the phenotype that appears in each cell is monitored. Using a sgRNA library that targets putative L-proline transporter genes in Corynebacterium glutamicum, for instance, an L-proline exporter for L-proline hyperproduction was found.
Creative Biogene's CRISPR/Cas9 PlatformCB stands at the forefront of the genome editing field, offering an extensive range of CRISPR library screening services. From screen design and cell line selection to the bioinformatics analysis of screen results, our services cover the entire spectrum of genome editing needs.
CRISPR Library Screening Service
Custom CRISPRi/CRISPRa Library Services
Base Editing Library Screening Service
CRISPR Lentiviral Library
CRISPR gRNA Screening Kit